Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | International Journal of Neuropsychopharmacology | journal | 1.924 Q1 | 125 | 219 | 445 | 12164 | 2061 | 433 | 4.27 | 55.54 | 39.37 | |
2 | Core Evidence (discontinued) | journal | 0.983 Q2 | 29 | 13 | 26 | 713 | 105 | 26 | 4.21 | 54.85 | 43.75 | |
3 | Frontiers in Pharmacology | journal | 1.560 Q1 | 154 | 272 | 444 | 20945 | 1872 | 425 | 4.14 | 77.00 | 41.61 | |
4 | Therapeutic Advances in Neurological Disorders | journal | 1.267 Q1 | 68 | 25 | 86 | 1144 | 356 | 83 | 3.88 | 45.76 | 35.23 | |
5 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | 42.92 | |
6 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.149 Q1 | 64 | 60 | 108 | 3598 | 404 | 105 | 3.74 | 59.97 | 35.27 | |
7 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.142 Q1 | 47 | 40 | 55 | 2804 | 208 | 54 | 3.57 | 70.10 | 42.38 | |
8 | Drug Design, Development and Therapy | journal | 1.034 Q2 | 94 | 235 | 227 | 10969 | 872 | 227 | 3.52 | 46.68 | 37.12 | |
9 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | 39.76 | |
10 | Altex | journal | 1.006 Q2 | 64 | 52 | 111 | 2399 | 394 | 85 | 3.48 | 46.13 | 37.78 | |
11 | Pharmacogenomics and Personalized Medicine | journal | 0.901 Q2 | 37 | 36 | 38 | 2605 | 124 | 38 | 3.41 | 72.36 | 47.15 | |
12 | CNS Neuroscience and Therapeutics | journal | 1.619 Q1 | 91 | 149 | 398 | 6211 | 1442 | 306 | 3.37 | 41.68 | 43.68 | |
13 | Cancer Chemotherapy and Pharmacology | journal | 1.141 Q1 | 122 | 285 | 960 | 8854 | 3092 | 938 | 3.35 | 31.07 | 30.68 | |
14 | Cancer Biology and Therapy | journal | 1.688 Q1 | 130 | 193 | 584 | 7556 | 2160 | 523 | 3.24 | 39.15 | 40.37 | |
15 | Journal of Experimental Pharmacology | journal | 0.994 Q2 | 23 | 1 | 3 | 23 | 9 | 3 | 3.00 | 23.00 | 33.33 | |
16 | Cardiovascular Therapeutics | journal | 1.051 Q2 | 54 | 46 | 203 | 1736 | 552 | 194 | 2.75 | 37.74 | 23.66 | |
17 | Biomarker Insights | journal | 0.937 Q2 | 40 | 13 | 49 | 424 | 133 | 49 | 2.72 | 32.62 | 35.90 | |
18 | Drug Metabolism and Pharmacokinetics | journal | 0.893 Q2 | 75 | 79 | 237 | 2444 | 620 | 211 | 2.72 | 30.94 | 33.07 | |
19 | Journal of Toxicology | journal | 0.890 Q2 | 47 | 33 | 135 | 1508 | 435 | 131 | 2.68 | 45.70 | 32.31 | |
20 | Journal of Physiology and Pharmacology | journal | 0.774 Q2 | 89 | 90 | 254 | 5055 | 789 | 254 | 2.64 | 56.17 | 49.31 | |
21 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | 30.08 | |
22 | Journal of Pharmacological Sciences | journal | 0.949 Q2 | 101 | 149 | 437 | 6116 | 1086 | 436 | 2.49 | 41.05 | 29.89 | |
23 | PharmacoEconomics | journal | 1.203 Q1 | 118 | 108 | 270 | 4933 | 708 | 232 | 2.49 | 45.68 | 35.40 | |
24 | Biomedicine and Pharmacotherapy | journal | 0.788 Q2 | 149 | 156 | 317 | 5899 | 771 | 312 | 2.37 | 37.81 | 48.25 | |
25 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.619 Q2 | 92 | 120 | 393 | 4478 | 821 | 391 | 2.35 | 37.32 | 39.61 | |
26 | BMC pharmacology & toxicology | journal | 0.715 Q2 | 43 | 77 | 83 | 2511 | 191 | 79 | 2.30 | 32.61 | 40.14 | |
27 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.652 Q2 | 88 | 38 | 145 | 2768 | 369 | 145 | 2.30 | 72.84 | 33.14 | |
28 | Infection and Drug Resistance | journal | 0.777 Q2 | 65 | 35 | 71 | 2165 | 171 | 70 | 2.28 | 61.86 | 35.38 | |
29 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | 34.11 | |
30 | Human Vaccines and Immunotherapeutics | journal | 0.924 Q2 | 93 | 532 | 721 | 21332 | 1608 | 547 | 2.23 | 40.10 | 44.12 | |
31 | Pharmacological Reports | journal | 0.747 Q2 | 98 | 165 | 488 | 7048 | 1149 | 486 | 2.22 | 42.72 | 48.90 | |
32 | Antiviral Chemistry and Chemotherapy | journal | 0.677 Q2 | 59 | 12 | 47 | 573 | 116 | 45 | 2.17 | 47.75 | 30.88 | |
33 | Chinese Medicine | journal | 0.771 Q2 | 56 | 27 | 93 | 1337 | 262 | 90 | 2.00 | 49.52 | 36.65 | |
34 | Saudi Pharmaceutical Journal | journal | 0.513 Q3 | 76 | 80 | 135 | 2525 | 293 | 133 | 1.97 | 31.56 | 32.74 | |
35 | Pharmacognosy Reviews (discontinued) | journal | 0.817 Q2 | 68 | 19 | 69 | 1377 | 210 | 68 | 1.89 | 72.47 | 35.42 | |
36 | DARU, Journal of Pharmaceutical Sciences | journal | 0.526 Q3 | 58 | 78 | 235 | 2556 | 408 | 212 | 1.78 | 32.77 | 35.77 | |
37 | Interdisciplinary Toxicology | journal | 0.534 Q3 | 38 | 32 | 99 | 1286 | 177 | 97 | 1.64 | 40.19 | 41.46 | |
38 | Korean Journal of Physiology and Pharmacology | journal | 0.569 Q3 | 40 | 72 | 201 | 2839 | 323 | 201 | 1.61 | 39.43 | 34.97 | |
39 | Drug, Healthcare and Patient Safety | journal | 0.733 Q2 | 30 | 24 | 58 | 1267 | 95 | 52 | 1.60 | 52.79 | 47.22 | |
40 | International Journal of Immunopathology and Pharmacology | journal | 0.494 Q3 | 65 | 93 | 506 | 1965 | 810 | 503 | 1.60 | 21.13 | 46.27 | |
41 | Pharmaceutical Biology | journal | 0.540 Q3 | 88 | 223 | 577 | 8232 | 1023 | 577 | 1.55 | 36.91 | 36.35 | |
42 | Drugs in R and D | journal | 0.541 Q3 | 54 | 39 | 88 | 1178 | 172 | 85 | 1.52 | 30.21 | 32.58 | |
43 | Open Medicinal Chemistry Journal | journal | 0.743 Q2 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | 38.46 | |
44 | Journal of Pharmacy and Pharmacognosy Research | journal | 0.171 Q4 | 17 | 20 | 5 | 784 | 7 | 4 | 1.40 | 39.20 | 59.76 | |
45 | Pharmacognosy Research (discontinued) | journal | 0.467 Q3 | 44 | 57 | 139 | 1649 | 225 | 132 | 1.40 | 28.93 | 25.52 | |
46 | Bangladesh Journal of Pharmacology | journal | 0.369 Q3 | 30 | 103 | 151 | 2704 | 182 | 151 | 1.23 | 26.25 | 32.98 | |
47 | Acta Pharmaceutica | journal | 0.402 Q3 | 67 | 40 | 120 | 1080 | 182 | 120 | 1.21 | 27.00 | 42.50 | |
48 | Natural Products and Bioprospecting | journal | 36 | 42 | 113 | 1438 | 130 | 113 | 1.20 | 34.24 | 37.08 | ||
49 | Records of Natural Products | journal | 0.469 Q3 | 41 | 61 | 158 | 1453 | 239 | 158 | 1.17 | 23.82 | 39.38 | |
50 | EXCLI Journal | journal | 0.242 Q3 | 55 | 109 | 220 | 6120 | 243 | 188 | 1.14 | 56.15 | 36.75 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®